SEC Filing Details
Document Details
Form
Filing Date
Dec 6, 2017
Document Date
Dec 6, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.
Filer
Schenkein David